Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Home
/
Trials
/
NCT00648284
NCT00648284
View on ClinicalTrials.gov
Cardiovascular (CV) Risk Evaluation In Type 2 Diabetes Subjects
Completed
OBSERVATIONAL
Enrollment
1,100
Participants
Timeline
Start Date
March 31, 2004
Conditions
Type 2 Diabetes Mellitus
CV Risk
Sponsors
Lead Sponsor
GlaxoSmithKline
All Listed Sponsors
lead
GlaxoSmithKline
INDUSTRY
NCT00648284 - Cardiovascular (CV) Risk Evaluation In Type 2 Diabetes Subjects | Biotech Hunter | Biotech Hunter